Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database.

Yuanfeng ZhangYang ChenZhiming ChenXinye ZhouShaochuan ChenKaijian LanZhiping WangYonghai Zhang

Published in: Pharmacogenomics and personalized medicine (2023)

P3H1 is a possible oncogene and an independent predictor of poor prognosis in BC; it also has enhanced sensitivity to docetaxel, cisplatin, vinblastine, camptothecin, paclitaxel, and other medications.

Keyphrases

poor prognosis
long non coding rna
papillary thyroid
spinal cord injury
squamous cell
single cell
genome wide
locally advanced
squamous cell carcinoma
adverse drug
gene expression
dna methylation
rectal cancer